Marblehead, MA, United States of America

Enoch Kim


Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2025

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Enoch Kim: Innovator in Pharmaceutical Compositions

Introduction

Enoch Kim is a notable inventor based in Marblehead, MA (US), recognized for his contributions to pharmaceutical compositions. He holds two patents that focus on innovative methods for treating various diseases, particularly those related to lipid metabolism and cardiovascular conditions.

Latest Patents

One of Enoch Kim's latest patents involves compositions comprising inhibitors of microsomal triglyceride transfer protein and apolipoprotein B (Apo B) secretion. This invention relates to pharmaceutical compositions that include particles characterized by a volume particle fraction of less than 10 μm, which can be beneficial in preventing and treating diseases such as atherosclerosis and hypertriglyceridemia. Another significant patent presents crystalline forms of a compound designed to treat chronic diseases and cardiovascular conditions associated with high blood pressure. These inventions highlight his commitment to advancing medical science and improving patient outcomes.

Career Highlights

Throughout his career, Enoch Kim has worked with several companies, including Retention Pharmaceuticals, Inc. and Redux Therapeutics, LLC. His experience in these organizations has allowed him to develop and refine his innovative ideas, contributing to the field of pharmaceuticals.

Collaborations

Enoch has collaborated with notable professionals in the industry, including Paul Sweetnam and Bridget McCarthy Cole. These partnerships have likely enhanced his research and development efforts, leading to impactful inventions.

Conclusion

Enoch Kim's work in pharmaceutical compositions demonstrates his dedication to innovation in the medical field. His patents reflect significant advancements that could lead to improved treatments for various health conditions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…